Mechanism-based treatment in tuberous sclerosis complex

Pediatric Neurology

Volumn 50, Issue 4, 2014, Pages 290-296

  Jülich, Kristina ^a   Sahin, Mustafa ^a  

^a BOSTON CHILDREN S HOSPITAL   (United States)

Author keywords

mTOR; neuronal connectivity; rapamycin; tuberous sclerosis complex

Indexed keywords

MAMMALIAN TARGET OF RAPAMYCIN; RAPAMYCIN; MTOR PROTEIN, HUMAN; TARGET OF RAPAMYCIN KINASE;

AUTISM; DIFFUSION TENSOR IMAGING; ELECTROENCEPHALOGRAM; GENETIC DISORDER; HUMAN; MECHANISM BASED TREATMENT; NERVE CELL DIFFERENTIATION; NERVE CELL NETWORK; NEUROLOGIC DISEASE; NONHUMAN; PRIORITY JOURNAL; QUALITY OF LIFE; REVIEW; SIGNAL TRANSDUCTION; THERAPY; TUBEROUS SCLEROSIS; TUBEROUS SCLEROSIS COMPLEX; ANIMAL; ANTAGONISTS AND INHIBITORS; BRAIN; METABOLISM; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; SYNAPTIC TRANSMISSION;

ANIMALS; BRAIN; CHILD DEVELOPMENT DISORDERS, PERVASIVE; HUMANS; SYNAPTIC TRANSMISSION; TOR SERINE-THREONINE KINASES; TUBEROUS SCLEROSIS;

EID: 84896396202     PISSN: 08878994     EISSN: 18735150     Source Type: Journal    
DOI: 10.1016/j.pediatrneurol.2013.12.002     Document Type: Review

References (77)

1. H. Northrup, and T. Krueger Tuberous sclerosis complex diagnostic criteria update: recommendations of the 2012 international tuberous sclerosis complex consensus conference Pediatr Neurol 49 2013 243 254
2. European Chromosome 16 Tuberous Sclerosis Consortium Identification and characterization of the tuberous sclerosis gene on chromosome 16 Cell 75 1993 1305 1315
3. M.V. Slegtenhorst, R. de Hoogt, and C. Hermans et al. Identification of the Tuberous Sclerosis Gene TSC1 on Chromosome 9q34 Science 277 1997 805 808 (Pubitemid 27366729)
4. P. Curatolo, R. Bombardieri, and S. Jozwiak Tuberous sclerosis Lancet 372 2008 657 668
5. K.S. Au, C.H. Ward, and H. Northrup Tuberous sclerosis complex: disease modifiers and treatments Curr Opin Pediatr 20 2008 628 633
6. E. Richardson Pathology of tuberous sclerosis Ann N Y Acad Sci 615 1991 128 139
7. M. Mizuguchi, and S. Takashima Neuropathology of tuberous sclerosis Brain Dev 23 2001 508 515 (Pubitemid 32999117)
8. K.C. Ess, C. Kamp, B.P. Tu, and D.H. Gutmann Developmental origin of subependymal giant cell astrocytoma in tuberous sclerosis complex Neurology 64 2005 1446 1449 (Pubitemid 40570520)
9. M. Kaczorowska, E. Jurkiewicz, and D. Domańska-Pakieła et al. Cerebral tuber count and its impact on mental outcome of patients with tuberous sclerosis complex Epilepsia 52 2011 22 27
10. J. Zhou, G. Shrikhande, and J. Xu et al. Tsc1 mutant neural stem/progenitor cells exhibit migration deficits and give rise to subependymal lesions in the lateral ventricle Genes Dev 25 2011 1595 1600
11. P. Curatolo, S. Jóźwiak, and R. Nabbout Management of epilepsy associated with tuberous sclerosis complex (TSC): Clinical recommendations Eur J Paediatr Neurol 16 2012 582 586
12. G.L. Holmes, and C.E. Stafstrom Tuberous sclerosis complex and epilepsy: recent developments and future challenges Epilepsia 48 2007 617 630 (Pubitemid 46587608)
13. P. Major, S. Rakowski, and M.V. Simon et al. Are cortical tubers epileptogenic? Evidence from electrocorticography Epilepsia 50 2009 147 154
14. A. Gallagher, C.J. Chu-Shore, and M. Montenegro et al. Associations between electroencephalographic and magnetic resonance imaging findings in tuberous sclerosis complex Epilepsy Res 87 2009 197 202
15. P. Curatolo, M. Verdecchia, and R. Bombardieri Vigabatrin for tuberous sclerosis complex Brain Dev 23 2001 649 653 (Pubitemid 32999142)
16. B. Zhang, S.S. McDaniel, N.R. Rensing, and M. Wong Vigabatrin inhibits seizures and mTOR pathway activation in a mouse model of tuberous sclerosis complex PLoS ONE 8 2013 e57445
17. P. De Vries, A. Humphrey, D. McCartney, P. Prather, P. Bolton, and A. Hunt Consensus clinical guidelines for the assessment of cognitive and behavioural problems in tuberous sclerosis Eur Child Adolesc Psychiatry 14 2005 183 190
18. I. Gillberg, C. Gillberg, and G. Ahlsen Autistic behaviour and attention deficits in tuberous sclerosis: a population-based study Dev Med Child Neurol 36 1994 50 56
19. E. D'Agati, R. Moavero, C. Cerminara, and P. Curatolo Attention-deficit hyperactivity disorder (ADHD) and tuberous sclerosis complex J Child Neurol 24 2009 1282 1287
20. J.F. Wernicke, K.C. Holdridge, and L. Jin et al. Seizure risk in patients with attention-deficit-hyperactivity disorder treated with atomoxetine Dev Med Child Neurol 49 2007 498 502 (Pubitemid 47018494)
21. D. Muzykewicz, P. Newberry, N. Danforth, E.F. Halpern, and E. Thiele Psychiatric comorbid conditions in a clinic population of 241 patients with tuberous sclerosis complex Epilepsy Behav 11 2007 506 513 (Pubitemid 350177384)
22. M.B. Pulsifer, E.B. Winterkorn, and E. Thiele Psychological profile of adults with tuberous sclerosis complex Epilepsy Behav 10 2007 402 406 (Pubitemid 46567778)
23. Raznahan, C. Joinson, F. O'Callaghan, J.P. Osborne, and P.F. Bolton Psychopathology in tuberous sclerosis: an overview and findings in a population-based sample of adults with tuberous sclerosis J Intellect Disab Res 50 2006 561 569 (Pubitemid 44027277)
24. C. Joinson, F.J. O'Callaghan, J.P. Osborne, C. Martyn, T. Harris, and P.F. Bolton Learning disability and epilepsy in an epidemiological sample of individuals with tuberous sclerosis complex Psychol Med 33 2003 335 344 (Pubitemid 36221465)
25. A.M. van Eeghen, A.I. Numis, B.A. Staley, S.E. Therrien, L. Ronald, and E.A. Thiele Characterizing sleep disorders of adults with tuberous sclerosis complex: a questionnaire-based study and review Epilepsy Behav 20 2012 68 74
26. C.J. Chu-shore, P. Major, S. Camposano, D. Muzykewicz, and E.A. Thiele The natural history of epilepsy in tuberous sclerosis complex Epilepsia 51 2011 1236 1241
27. A. Hunt, and G. Stores Sleep disorder and epilepsy in children with tuberous sclerosis: a questionnaire-based study Dev Med Child Neurol 36 1994 108 115 (Pubitemid 24038932)
28. O. Bruni, F. Cortesi, F. Giannotti, and P. Curatolo Sleep disorders in tuberous sclerosis: a polysomnographic study Brain Devel 17 1995 52 56
29. D.H. Geschwind, and P. Levitt Autism spectrum disorders: developmental disconnection syndromes Curr Opin Neurobiol 17 2007 103 111 (Pubitemid 46237744)
30. M.K. Belmonte, G. Allen, A. Beckel-Mitchener, L.M. Boulanger, R.A. Carper, and S.J. Webb Autism and abnormal development of brain connectivity J Neurosci 24 2004 9228 9231 (Pubitemid 39426157)
31. C.A. Hoeffer, and E. Klann mTOR signaling: at the crossroads of plasticity, memory and disease Trends Neurosci 33 2010 67 75
32. D.C. Fingar, S. Salama, C. Tsou, E. Harlow, and J. Blenis Mammalian cell size is controlled by mTOR and its downstream targets S6K1 and 4EBP1/eIF4E Genes Dev 16 2002 1472 1487 (Pubitemid 34686329)
33. M.K. Holz, B. Ballif, S.P. Gygi, and J. Blenis mTOR and S6K1 mediate assembly of the translation preinitiation complex through dynamic protein interchange and ordered phosphorylation events Cell 123 2005 569 580 (Pubitemid 41608461)
34. D. Guertin, D.M. Stevens, and C.C. Thoreen et al. Ablation in mice of the mTORC components raptor, rictor, or mLST8 reveals that mTORC2 is required for signaling to Akt-FOXO and PKCalpha, but not S6K1 Dev Cell 11 2006 859 871 (Pubitemid 44804279)
35. J. Huang, S. Wu, C.-L. Wu, and B.D. Manning Signaling events downstream of mammalian target of rapamycin complex 2 are attenuated in cells and tumors deficient for the tuberous sclerosis complex tumor suppressors Cancer Res 69 2009 6107 6114
36. M. Laplante, and D.M. Sabatini mTOR signaling in growth control and disease Cell 149 2012 274 293
37. V. Schick, M. Majores, and G. Engels et al. Differential Pi3K-pathway activation in cortical tubers and focal cortical dysplasias with balloon cells Brain Pathol 17 2007 165 173 (Pubitemid 46466136)
38. F.E. Jansen, R.G.E. Notenboom, and M. Nellist et al. Differential localization of hamartin and tuberin and increased S6 phosphorylation in a tuber Neurology 63 2004 1293 1295 (Pubitemid 39350035)
39. M. Baybis, J. Yu, and A. Lee et al. mTOR cascade activation distinguishes tubers from focal cortical dysplasia Ann Neurol 56 2004 478 487 (Pubitemid 39319337)
40. L.A. Haddad, N. Smith, and M. Bowser et al. The TSC1 tumor suppressor hamartin interacts with neurofilament-L and possibly functions as a novel integrator of the neuronal cytoskeleton J Biol Chem 277 2002 44180 44186 (Pubitemid 36157848)
41. Y. Choi, A. Di Nardo, and I. Kramvis et al. Tuberous sclerosis complex proteins control axon formation Genes Dev 22 2008 2485 2495
42. H.L. Brown, K.R. Kaun, and B. Edgar The small GTPase Rheb affects central brain neuronal morphology and memory formation in Drosophila PLoS ONE 7 2012 e44888
43. K.C. Martin Local protein synthesis during axon guidance and synaptic plasticity Curr Opin Neurobiol 14 2004 305 310 (Pubitemid 38765166)
44. D. Nie, A. Di Nardo, and J.M. Han et al. Tsc2-Rheb signaling regulates EphA-mediated axon guidance Nat Neurosci 13 2010 163 172
45. S. Knox, H. Ge, and B.D. Dimitroff et al. Mechanisms of TSC-mediated control of synapse assembly and axon guidance PloS One 2 2007 e375
46. F.G. Garaci, R. Floris, and A. Bozzao et al. Increased brain apparent diffusion coefficient in tuberous sclerosis Radiology 232 2004 461 465 (Pubitemid 38971287)
47. S.S.-F. Peng, W.-T. Lee, Y.H. Wang, and K.-M. Huang Cerebral diffusion tensor images in children with tuberous sclerosis: a preliminary report Pediatr Radiol 34 2004 387 392 (Pubitemid 38701988)
48. A.F. Luat, M. Makki, and H.T. Chugani Neuroimaging in tuberous sclerosis complex Curr Opin Neurol 20 2007 142 150 (Pubitemid 46411498)
49. S. Arulrajah, G. Ertan, and L. Jordan et al. Magnetic resonance imaging and diffusion-weighted imaging of normal-appearing white matter in children and young adults with tuberous sclerosis complex Neuroradiology 51 2009 781 786
50. E. Widjaja, G. Simao, and S.Z. Mahmoodabadi et al. Diffusion tensor imaging identifies changes in normal-appearing white matter within the epileptogenic zone in tuberous sclerosis complex Epilepsy Res 89 2010 246 253
51. M.L. Krishnan, O. Commowick, and S.S. Jeste et al. Diffusion features of white matter in tuberous sclerosis with tractography Pediatr Neurol 42 2010 101 106
52. G. Simao, C. Raybaud, S. Chuang, C. Go, O.C. Snead, and E. Widjaja Diffusion tensor imaging of commissural and projection white matter in tuberous sclerosis complex and correlation with tuber load AJNR Am J Neuroradiol 31 2010 1273 1277
53. J.M. Peters, M. Sahin, and V.K. Vogel-Farley et al. Loss of white matter microstructural integrity is associated with adverse neurological outcome in tuberous sclerosis complex Acad Radiol 19 2012 17 25
54. L. Meikle, D.M. Talos, and H. Onda et al. A mouse model of tuberous sclerosis: neuronal loss of Tsc1 causes dysplastic and ectopic neurons, reduced myelination, seizure activity, and limited survival J Neurosci 27 2007 5546 5558 (Pubitemid 350021088)
55. S.W. Way, J. McKenna, U. Mietzsch, R.M. Reith, H.C.-J. Wu, and M.J. Gambello Loss of Tsc2 in radial glia models the brain pathology of tuberous sclerosis complex in the mouse Human Mol Genet 18 2009 1252 1265
56. R.P. Carson, D.L. Van Nielen, P. Winzenburger, and K.C. Ess Neuronal and glia abnormalities in Tsc1-deficient forebrain and partial rescue by rapamycin Neurobiol Dis 45 2012 369 380
57. S.J. Tang, G. Reis, H. Kang, A.-C. Gingras, N. Sonenberg, and E.M. Schuman A rapamycin-sensitive signaling pathway contributes to long-term synaptic plasticity in the hippocampus Proc Natl Acad Sci of USA 99 2002 467 472 (Pubitemid 34060384)
58. C. Von der Brelie, R. Waltereit, L. Zhang, H. Beck, and T. Kirschstein Impaired synaptic plasticity in a rat model of tuberous sclerosis Eur J Neurosci 23 2006 686 692
59. R. Waltereit, B. Japs, M. Schneider, P. de Vries, and D. Bartsch Epilepsy and Tsc2 haploinsufiiciency lead to autistic-like social deficit behaviors on rats Behav Genet 41 2011 364 372
60. H.S. Bateup, K.T. Takasaki, J.L. Saulnier, C.L. Denefrio, and B.L. Sabatini Loss of Tsc1 in vivo impairs hippocampal mGluR-LTD and increases excitatory synaptic function J Neurosci 31 2011 8862 8869
61. D. Ehninger, S. Han, and C. Shilyansky et al. Reversal of learning deficits in a Tsc2+/- mouse model of tuberous sclerosis Nat Med 14 2008 843 848
62. S.M. Goorden, G.M. van Woerden, L. van der Weerd, J.P. Cheadle, and Y. Elgersma Cognitive deficits in Tsc1+/- mice in the absence of cerebral lesions and seizures Ann Neurol 62 2007 648 655
63. I. Chévere-Torres, J.M. Maki, E. Santini, and E. Klann Impaired social interactions and motor learning skills in tuberous sclerosis complex model mice expressing a dominant/negative form of tuberin Neurobiol Dis 45 2012 156 164
64. P.T. Tsai, C. Hull, and Y. Chu et al. Autistic-like behaviour and cerebellar dysfunction in Purkinje cell Tsc1 mutant mice Nature 488 2012 647 651
65. R.M. Reith, J. McKenna, and H. Wu et al. Loss of Tsc2 in Purkinje cells is associated with autistic-like behavior in a mouse model of tuberous sclerosis complex Neurobiol Dis 51 2013 93 103
66. J.M. Peters, M. Taquet, and C. Vega et al. Brain functional networks in syndromic and non-syndromic autism: a graph theoretical study of EEG connectivity BMC Med 11 2013 54
67. C.P. Schaaf, and H.Y. Zoghbi Solving the autism puzzle a few pieces at a time Neuron 70 2011 806 808
68. L. Meikle, K. Pollizzi, and A. Egnor et al. Response of a neuronal model of tuberous sclerosis to mammalian target of rapamycin (mTOR) inhibitors: effects on mTORC1 and Akt signaling lead to improved survival and function J Neurosci 28 2008 5422 5432
69. S.W. Way, N.S. Rozas, and H.C. Wu et al. The differential effects of prenatal and/or postnatal rapamycin on neurodevelopmental defects and cognition in a neuroglial mouse model of tuberous sclerosis complex Human Mol Genet 21 2012 3226 3236
70. L.-H. Zeng, L. Xu, D.H. Gutmann, and M. Wong Rapamycin prevents epilepsy in a mouse model of tuberous sclerosis complex Ann Neurol 63 2008 444 453 (Pubitemid 351614710)
71. J. Goto, D.M. Talos, and P. Klein et al. Regulable neural progenitor-specific Tsc1 loss yields giant cells with organellar dysfunction in a model of tuberous sclerosis complex Proc Natl Acad Sci USA 108 2011 E1070 E1079
72. M. Cambiaghi, M. Cursi, and L. Magri et al. Behavioural and EEG effects of chronic rapamycin treatment in a mouse model of tuberous sclerosis complex Neuropharmacology 67C 2012 1 7
73. D.N. Franz, J. Leonard, and C. Tudor et al. Rapamycin causes regression of astrocytomas in tuberous sclerosis complex Ann Neurol 59 2006 490 498 (Pubitemid 43358069)
74. J.J. Bissler, F.X. McCormack, and L.R. Young et al. Sirolimus for angiomyolipoma in tuberous sclerosis complex or lymphangioleiomyomatosis N Engl J Med 358 2008 140 151
75. D. Krueger, M.M. Care, and K. Holland et al. Everolimus for subependymal giant-cell astrocytomas in tuberous sclerosis N Engl J Med 363 2010 1801 1811
76. J.-M. Tillema, J.L. Leach, D. Krueger, and D.N. Franz Everolimus alters white matter diffusion in tuberous sclerosis complex Neurology 78 2012 526 531
77. D. Krueger, A. Wilfong, and K. Holland-Bouley et al. Everolimus treatment of refractory epilepsy in tuberous sclerosis complex Ann neurol 74 2013 679 687